Reduction in pain following treatment with ranolazine in primary erythromelalgia: a case report.

Greco, C; Chaumon, S; Viallard, M-L; Bodemer, C

Greco, C; Chaumon, S; Viallard, M-L; Bodemer, C.

Affiliation

Greco C; University Paris Descartes, Paris, France.
Chaumon S; Department of Neonatal, Pediatric and Adult Pain and Palliative Medicine Unit.
Viallard ML; Laboratoire d'éthique Médicale EA 4569, Paris, France.
Bodemer C; Inserm UMRS 935, Villejuif, France.

Br J Dermatol ; 179(3): 783-784, 2018 09.

Article in En | MEDLINE | ID: mdl-29624653

Subject(s)

Erythromelalgia/complications; Pain Management/methods; Pain/drug therapy; Ranolazine/administration & dosage; Sodium Channel Blockers/administration & dosage; Erythromelalgia/genetics; Gain of Function Mutation; Humans; Male; NAV1.7 Voltage-Gated Sodium Channel/genetics; NAV1.7 Voltage-Gated Sodium Channel/metabolism; Pain/diagnosis; Pain/etiology; Pain Measurement; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Pain / Sodium Channel Blockers / Erythromelalgia / Pain Management / Ranolazine Type of study: Diagnostic_studies / Etiology_studies Limits: Humans / Male Language: En Journal: Br J Dermatol Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google